SO
The startup develops a drug discovery platform that identifies cancer-specific epitopes in drug-resistant tumors and generates antibodies with atomic-level specificity. This technology enables healthcare researchers to validate therapeutic targets and create immunotherapies that effectively eliminate resistant cancer cells.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a drug discovery platform that identifies cancer-specific epitopes in drug-resistant tumors and generates antibodies with atomic-level specificity. This technology enables healthcare researchers to validate therapeutic targets and create immunotherapies that effectively eliminate resistant cancer cells.